24 results
10-Q
2020 Q1
ZNTL
Zentalis Pharmaceuticals Inc
15 May 20
Quarterly report
7:25am
marketing programs. FDA, EMA or other regulatory authority investigations could potentially lead to a recall of our products or more serious … on that product, the manufacturing facility or us, including requiring recall or withdrawal of the product from the market or suspension of manufacturing
10-K
cvl09gp rdvwq92
25 Mar 21
Annual report
7:17am
DRS
yu1ewwi 1zk40kmt8
8 Jan 20
Draft registration statement
12:00am
DRS
7nc0dl6v75tj59u
10 Jul 20
Draft registration statement
12:00am
S-1
0lb14tu 2j2pg8tu
6 Mar 20
IPO registration
5:05pm
S-1/A
jvkdhx8431gpq
30 Mar 20
IPO registration (amended)
6:36am